Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07665060 · ClinicalTrials.gov registry record
HIV Antibody Increases Following Viral Rebound in People Receiving Antiretroviral Therapy
A clinical trial, sponsored by NYU Langone Health.
- Active
- Registry status
- 6,100
- Enrollment target
NCT07665060 is a clinical trial that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 6,100 participants.
The verdict
NCT07665060 is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- 6,100 participants
- Enrollment target
Study Summary
The purpose of this study is to establish a proof-of-concept for whether rapid test can detect viral rebounds that occurred within a retrospective time window among PLHIV receiving ART in the United States and sub-Saharan Africa. The objective of this study is to assess whether HIV antibody levels rise following HIV viral rebound, and the sensitivity and specificity of antibody level increases for detecting HIV viral rebounds. The investigators will conduct a retrospective matched case-control study of individuals with or without suppressed viral load on antiretroviral therapy (ART). Biobanked specimens will be tested for antibody levels.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,100 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2031-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07665060
The ClinicalTrials.gov registry entry for NCT07665060 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 6,100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07665060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07665060 about?
NCT07665060 is a clinical study titled "HIV Antibody Increases Following Viral Rebound in People Receiving Antiretroviral Therapy". The purpose of this study is to establish a proof-of-concept for whether rapid test can detect viral rebounds that occurred within a retrospective time window among PLHIV receiving ART in the United States and sub-Saharan Africa. The objective of this study is to assess whether HIV antibody levels ...
What is the current status of trial NCT07665060?
This trial is currently active not recruiting. The enrollment target is 6,100 participants. The study started on 2026-04-01. Estimated completion is 2031-03-31.
Who is sponsoring clinical trial NCT07665060?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.